Table 1.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | MM Mean (SD) | |
---|---|---|---|---|---|---|---|---|---|---|---|
1. Baseline Self-Efficacy | 1.00 | −.03 | −.09* | −.22* | .08 | .24* | −.11* | −.08 | −.09 | −.16* | 2.6 (.7) |
2. Baseline % Drinking Days | −.05 | 1.00 | −.05 | −.005 | −.14* | −.03 | −.13* | .26* | −.04 | −.06 | 74 (24) |
3. Baseline DrInC Score | −.20* | −.10* | 1.00 | .45* | −.03 | −.10* | −.09* | −.15* | .28* | .21* | 49 (21) |
4. Baseline BSI Global Index | −.25* | −.06 | .49* | 1.00 | −.10* | −.20* | .02 | −.03 | .26* | .49* | 60 (11) |
5. Working Alliance | .07 | −.01 | .01 | −.11* | 1.00 | .21* | −.19* | −.09 | −.18* | −.19* | 74 (9) |
6. Post-treatment Self-Efficacy | .15* | −.02 | −.17* | −.20* | .10* | 1.00 | −.43* | −.36* | −.42* | −.44* | 3.4 (.9) |
7. Early-treatment % Drinking Days | −.07 | .25* | −.05 | .02 | −.09* | −.38* | 1.00 | .53* | .38* | .27* | 25 (32) |
8. Follow-up % Drinking Days | .02 | .25* | −.12* | −.01 | −.15* | −.32* | .51* | 1.00 | .51* | .35* | 38 (37) |
9. Follow-up DrInC Score | −.07 | −.05 | .37* | .25* | −.15* | −.46* | .28* | .43* | 1.00 | .67* | 20 (21) |
10. Follow-up BSI Global Index | −.08 | −.02 | .31* | .51* | −.18* | −.42* | .18* | .27* | .68* | 1.00 | 51 (13) |
CBI conditions Mean (SD) | 2.6(.7) | 75(26) | 47(20) | 60(11) | 72(9) | 3.5(.9) | 26(32) | 37(38) | 20(22) | 53(13) |
Notes. Correlations for the CBI Conditions are presented below the diagonal, whereas those for theMM Conditions are above the diagonal; DrInC = Drinker Inventory of Consequences; BSI = Brief Symptom Inventory; Post-treatment assessment refers to that occurring at end of treatment, follow-up assessment corresponds to that occurring one year following treatment;
p<0.05.